Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Contrave dosing
Side-by-Side Reference Attribute Class SLU-PP-332 Synthetic small-molecule pan-ERR agonist MOTS-c Mitochondrial-derived peptide (16 aa) AOD-9604 Modified GH fragment (aa 176-191) Attribute Primary target SLU-PP-332 ERR / / nuclear receptors MOTS-c AMPK activation and mitochondrial signaling AOD-9604 Lipolysis pathways without GH-receptor signaling Attribute Half-life SLU-PP-332 Not formally published
AR, Androgen Receptor
Why no big human trials: Peptides cant be patented, so pharmaceutical companies wont fund the $100M+ studies needed for FDA approval
US$ 27.49
US$ 25.51
US$ 23.46
US$ 23.58
US$ 28.76
